Testing a new drug for advanced tumors
Part of Cancer clinical trials.
This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer has spread or cannot be removed by surgery, and it has been confirmed by a biopsy or other lab test.
- You are well enough to care for yourself (ECOG score 0 or 1).
- Your life expectancy is more than 3 months.
- You have signed a consent form saying you understand the study.
- Your organs (like liver, kidneys, and blood) are working well enough.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SSGJ-709 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called SCTB39G for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can help shrink or control the cancer.
This trial is testing an investigational drug called SIBP-A19 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests a new drug called SSGJ-612 for people with advanced solid tumors that have stopped responding to standard treatments. It is specifically for patients whose tumors have a protein called HER2, and it aims to see if the drug can shrink or control the cancer.
This trial tests two experimental drugs (SCTB41 and SCTB39G), given with or without standard cancer therapies, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and effective.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.